Marathon Capital Management Abbott Laboratories Transaction History

Marathon Capital Management

$399 Million
Q3 2024

A detailed history of Marathon Capital Management transactions in Abbott Laboratories stock. As of the latest transaction made, Marathon Capital Management holds 4,839 shares of ABT stock, worth $560,840. This represents 0.14% of its overall portfolio holdings.

Number of Shares

4,839

Previous 4,839 -0.0%

Holding current value

$560,840

Previous $502,000 9.76%

% of portfolio

0.14%

Previous 0.13%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$100.73 - $112.44 $1,208 - $1,349	-12 Reduced 0.25%	4,839 $502,000
Q1 2024 May 15, 2024	BUY	$109.52 - $120.96 $1,642 - $1,814	15 Added 0.31%	4,851 $551,000
Q4 2023 Feb 08, 2024	SELL	$90.19 - $110.4 $4,509 - $5,520	-50 Reduced 1.02%	4,836 $532,000
Q3 2023 Nov 14, 2023	BUY	$95.53 - $114.62 $95 - $114	1 Added 0.02%	4,886 $473,000
Q3 2022 Nov 14, 2022	SELL	$96.76 - $112.03 $5,321 - $6,161	-55 Reduced 1.11%	4,885 $473,000
Q2 2022 Aug 12, 2022	BUY	$102.07 - $123.37 $504,225 - $609,447	4,940 New	4,940 $537,000
Q1 2022 May 13, 2022	SELL	$114.02 - $139.04 $556,873 - $679,071	-4,884 Closed	0 $0
Q4 2021 Feb 09, 2022	SELL	$115.53 - $141.46 $86,069 - $105,387	-745 Reduced 13.24%	4,884 $687,000
Q3 2021 Nov 15, 2021	BUY	$116.66 - $129.06 $73,029 - $80,791	626 Added 12.51%	5,629 $666,000
Q1 2021 May 14, 2021	BUY	$108.84 - $128.23 $29,931 - $35,263	275 Added 5.82%	5,003 $599,000
Q4 2020 Feb 08, 2021	SELL	$105.0 - $114.42 $27,930 - $30,435	-266 Reduced 5.33%	4,728 $517,000
Q3 2020 Nov 16, 2020	SELL	$91.64 - $111.29 $8,155 - $9,904	-89 Reduced 1.75%	4,994 $543,000
Q1 2020 May 15, 2020	SELL	$62.82 - $91.86 $3,392 - $4,960	-54 Reduced 1.05%	5,083 $401,000
Q4 2019 Feb 14, 2020	BUY	$78.51 - $87.4 $155,135 - $172,702	1,976 Added 62.51%	5,137 $446,000
Q3 2019 Nov 13, 2019	BUY	$81.84 - $88.74 $81 - $88	1 Added 0.03%	3,161 $264,000
Q2 2019 Jul 25, 2019	SELL	$72.88 - $85.0 $801 - $935	-11 Reduced 0.35%	3,160 $265,000
Q1 2019 May 15, 2019	SELL	$66.22 - $80.06 $4,304 - $5,203	-65 Reduced 2.01%	3,171 $253,000
Q4 2018 Feb 07, 2019	BUY	$65.56 - $74.27 $16,652 - $18,864	254 Added 8.52%	3,236 $234,000
Q3 2018 Nov 13, 2018	BUY	$60.81 - $73.36 $181,335 - $218,759	2,982 New	2,982 $218,000
Q1 2018 May 07, 2018	SELL	$56.27 - $63.62 $200,771 - $226,996	-3,568 Closed	0 $0
Q4 2017 Feb 13, 2018	BUY	$53.68 - $57.47 $191,530 - $205,052	3,568	3,568 $203,000

Others Institutions Holding ABT

# of Institutions

3,185

Shares Held

1.31B

Call Options Held

8.74M

Put Options Held

7.89M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $203B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marathon Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Marathon Capital Management with notifications on news.

Account

Marathon Capital Management Abbott Laboratories Transaction History